Advance Intermediates
Intermediates
Saving you time and cost with our selection of high-quality intermediates
Flavine understands the challenging needs of API manufacturers and offers an expensive pipeline of advance intermediates that save production cost and time. Our intermediates are crucial precursors to many common API products sold in the US and EU markets. We also provide custom synthesis of unique intermediates and chemical compounds.
Our advance intermediates provide swift routes to key chemical classes:
- Antibiotics
- Complex Small Molecules
- Corticosteroids
- Macrocycles
- Natural Products
- Nucleotides and Derivatives
- Oligonucleotides
- Oligosaccharides
- Organometallics
- Peptides
- Steroids
- Vitamins
Click here to download Intermediate Commercial Product List:
Click here to download Intermediates Under Development Product List:
Intermediate Commercial Product List
INTERMEDIATE CHEMICAL NAME | STRUCTURE | CAS NUMBER | FINAL TARGET ACTIVE INGREDIENT | STRUCTURE |
---|---|---|---|---|
Dehydroepiandrosterone | 53–43‑0 | Abiraterone | ||
Adenine | 73–24‑5 | Adenine, ATP | ||
Adenosine | 58–61‑7 | Adenosine | ||
Azaerythromycin amine | 76801–85‑9 | Azithromycin | ||
3-(4‑Chlorphenyl)glutaric acid amide | 1141–23‑7 | Baclofen | ||
5‑Amino-2-Cyanobenzotrifluoride | 654–70‑6 | Bicalutamide | ||
2-[[4-[[2-(1‑methylethoxy)ethoxy]methyl]phenoxy]methyl] oxirane | 66722–57‑4 | Bisoprolol | ||
1-(2‑Pyrimidinyl)piperazine | 20980–22‑7 | Buspirone | ||
3,3‑Tetramethyleneglutarimide | 1075–89‑4 | Buspirone | ||
1,1‑Cyclobutane dicarboxylic acid | 5445–51‑2 | Carboplatin | ||
4‑Amino-5-imidazolecarboxamide hydrochloride | 72–40‑2 | Dacarbazine | ||
2-(2‑Hydroxyphenyl)-4H‑1,3‑benzoxazin-4-one | 1218–69‑5 | Deferasirox | ||
1-[(2,3‑Dihydro‑1,4‑benzodioxin-2-yl)-carbonyl]-piperazine | 70918–00‑2 | Doxazosin mesylate | ||
Dehydroepiandrosterone | 53–43‑0 | Drospirenone | ||
3β,5β-Dihydroxy-15β,16β-methylene-6-androsten-17-one | 82543–15‑5 | Drospirenone | ||
3β,5‑Dihydroxy-6β,7β,15β,16β-dimethylene-5β-androstan-17-one | 82543–16‑6 | Drospirenone | ||
Estrone | 53–16‑7 | Estetrol (E4) | ||
19-Norandrostenedione | 734–32‑7 | Corticosteroid derivatives | ||
∆5‑Norandrostenedione | 3962–66‑1 | Corticosteroid derivatives | ||
20α-hydroxymethylpregna‑1,4‑diene-3-one | 35525–27‑0 | Corticosteroid derivatives | ||
Dimepranol Acedoben | 61990–51‑0 | Inosine Pranobex | ||
1‑Phenoxy-2-isopropylamine | 35205–54‑0 | Isoxsuprine | ||
3,5‑Diiodo-L-Thyronine | 1041–01‑6 | Levothyroxine Sodium | ||
Erythromycin | 114–07‑8 | Macrolides | N/A | |
Erythromycin Thiocyanate | 7704–67‑8 | Macrolides | N/A | |
Methyl Aminobenzoyl Glutaminester | 2378–95‑2 | Methotrexate | ||
Mycophenolic acid | 24280–93‑1 | Mycophenolate Mofetil | ||
6-(4‑benzylamino-3-nitrophenyl)-5-methyl-2H-pyridazin-3-one | 77469–62‑6 | Pimobendan | ||
6‑Methoxy-2-(4‑methoxyphenyl)-benzo[b] thiophene | 63675–74‑1 | Raloxifene | ||
(S)-3–1‑Dimethylamino Ethyl Phenol | 139306–10‑8 | Rivastigmine | ||
Sodium Nitroprusside crude | 13755–38‑9 | Sodium Nitroprusside | ||
(S)-3-tert-Butylamino‑1,2‑propanediol | 30315–46‑9 | Timolol | ||
3‑Chloro-4-morpholino‑1,2,5‑thiadiazole | 30165–96‑9 | Timolol | ||
4‑Chloropyridine-3-sulfonamide | 33263–43‑3 | Torasemide | ||
1-(3‑Chlorophenyl)-4-(3‑chloropropyl)-piperazine hydrochloride | 52605–52‑4 | Trazodone | ||
1-(3‑Chlorophenyl)-piperazine hydrochloride | 65369–76‑8 | Trazodone | ||
1,2,4‑Triazolo[4,3‑a]pyridin‑3(2H)-one | 6969–71‑7 | Trazodone | ||
9(10)-Dehydronandrolone | 6218–29‑7 | Trenbolone |
Intermediate Under Development Product List
INTERMEDIATE CHEMICAL NAME | STRUCTURE | CAS NUMBER | FINAL TARGET ACTIVE INGREDIENT | STRUCTURE |
---|---|---|---|---|
1-(2‑Amino-1-[(4‑methoxy-2-(phenylethyl)]-cyclohexanol | 93413–77‑5 | Venlafaxine | ||
1,4‑Benzodioxan-2-carboxylic acid | 3663–80‑7 | Doxazosin | ||
1-[(4‑Isopropoxy)-ethoxymethyl]-hydroxybenzene | 177034–57‑0 | Bisoprolol | ||
1-[2-(2‑Hydroxyethoxy)ethyl]piperazine | 13349–82‑1 | • Dixyrazine • Quetiapine fumarate | Multiple API targets | |
1-[4-(acetyloxy)-3,5‑dimethoxyphenyl]-2-Bromoethanone | 28294–48‑6 | Dimetofrine | ||
10-OH-camptothecin | 7689–03‑4 | Camptothecin | ||
1‑Benzyl-4-cyano-4-phenylpiperidine hydrochloride | 71258–18‑9 | Piritramide | ||
1‑Chloro‑6,6‑Dimethyl-2-Hepten-4-Yne | 126764–17‑8 | Terbinafine | ||
1H-benzimidazole- 7‑carboxylic acid 2‑ethoxy-1-[(2’-(1H-tetrazol-5-yl)-1,1’-biphenyl ‑4-yl)methyl]-ethyl ester | 139481–58‑6 | Candesartan | ||
1‑methyl-2-(7‑methyl-2-propyl-1H-benzo [d]imidazole-5-yl)-1H-benzo[d]imidazole | 152628–02‑9 | Telmisartan | ||
1-[(2′-Cyano‑1,1′-biphenyl-4-yl)methyl]-2-ethoxy-7-benzimidazolecarboxylic Acid Methyl Ester | 139481–44‑0 | Candesartan | ||
2 Ethoxy 1 2” Cyano 1 1” Biphenyl 4 yl Methyl 1H valeroyl-Benzimidazole 7 Carboxylic acid Ethyl Ester | 139481–41‑7 | Candesartan | ||
2-(4‑methoxy benzylamino)-pyridine | 52818–63‑0 | Pyrilamine | ||
2-(Dimethylamino)-ethanethiol hydrochloride | 13242–44‑9 | Echothiophate iodide | ||
2,4,5,6‑Tetraaminopyrimidine sulfate | 5392–28‑9 | • 2,4,5,6‑Tetrachloropyrimidine • Lumazine • Methotrexate | Multiple API targets | |
2,4‑Dichloro-5-sulfamoylbenzoic acid | 2736–23‑4 | Furosemide | ||
2,6‑Diaminopurine | 1904–98‑9 | • (2S-cis)-5-(6‑Amino-2-fluoro- 9H-purin-9-yl)-tetrahydro-2-furanmethanol • Fludarabine • Fludarabine phosphate | Multiple API targets | |
2,7‑Dichoro-α-[(dibutylamino)methyl]- 9 H fluorine-4-methanol | 69759–61‑1 | Lumefantrine | ||
2-[(Dimethylamino)-methyl]-cyclo hexanone hydrochloride | 42036–65‑7 | • Tramadol • Tramadol hydrochloride | ||
2-[4-[(methylsulfonyl)oxy]phenyl]-Benzo[b] thiophene-6-ol 6‑methanesulfonate | 84449–65‑0 | • Nitronaproxen • Raloxifene | Multiple API targets | |
2‑Chlorotriphenylchloromethane | 42074–68‑0 | Clotrimazole | ||
2‑Diethylaminoethanethiol | 100–38‑9 | • Dalfopristin • Fencarbamide • Thiphenamil hydrochloride | Multiple API targets | |
2‑ethoxy-1-[(2’-(1‑trityl-1H-tetrazol-5-yl)-1,1’-biphenyl-4-yl)methyl]- 7- benzimidazolecarboxylic acid | 139481–72‑4 | Candesartan | ||
2‑Phenoxy Ethyl Chloride | 622–86‑6 | • Bephenium 3‑hydroxy-2-naphthoate • Idoxifene | Multiple API targets | |
2‑Pyrrolidinoethyl chloride hydrochloride | 7250–67‑1 | • Centchroman • Histapyrrodine | Multiple API targets | |
3-(1‑Piperazinyl)-1,2‑benzisothiazole hydrochloride | 87691–88‑1 | • Ziprasidone • Ziprasidone hydrochloride | ||
3-(4‑Chlorophenyl)-glutaric acid | 1189874–68‑7 | Baclofen | ||
3-(4‑Chlorophenyl)-glutaric anhydride | 53911–68‑5 | Baclofen | ||
3,11-dichloro‑6,11-dihydro-6-methyldibenzo [c,f] [1,2] thiazepine 5,5 dioxide | 26638–66‑4 | Tianeptine Sodium | ||
3,4‑Dihydroxy Benzonitrile | 17345–61‑8 | Protocatechuonitrile | ||
3-[5-(Fluorophenyl)-1,5‑dioxopentyl]- 4(S)-phenyl-2-oxazolidinone | 189028–93‑1 | Ezetimibe | ||
3‑Chloro‑6,11-dihydro-6-methyl‑5,5,11- trioxodibenzo [c,f][1,2]thiazepine | 26638–53‑9 | Tianeptine Sodium | ||
4-(2‑Aminoethyl)-benzenesulfonamide | 35303–76‑5 | • Glimepiride • Glipizide • Gliquidone • Glisentide • Glisolamide • Glisoxepid • Glyburide | Multiple API targets | |
4-(2‑Piperidinoethoxy)-benzoic acid hydrochloride | 84449–80‑9 | Raloxifene | ||
4-(3‑Methyl-phenyl)amino-3-pyridine sulfonamide | 72811–73‑5 | Torsemide | ||
4-(((4‑Fluorophenyl)imino)methyl)phenol | 3382–63‑6 | Ezetimibe | ||
4-(4‑Chlorophenyl)-4-piperidinol | 39512–49‑7 | • Haloperidol • Loperamide • Loperamide hydrochloride • Loperamide oxide | Multiple API targets | |
4-(4‑Chlorophenyl)-glutarimide | 84803–46‑3 | Baclofen | ||
4-(4‑Fluorobenzoyl)-butyric acid | 149437–76‑3 | Ezetimibe | ||
4-[2-(5‑Chloro-2-methoxybenzamido)- ethyl]-phenyl sulfonamide | 16673–34‑0 | Glyburide | ||
4-[4-(Dimethylamino)-1-(4‑fluorophenyl)-1- (hydroxybutyl)-3-(hydroxymethyl) benzonitrile | 103146–25‑4 | Citalopram | ||
4‑Aminopyridine | 504–24‑5 | • 4-(Dimethylamino)-pyridine • Indibulin • Lexipafant • Milverine • Octenidine hydrochloride • Oglemilast • Pinacidil • Roflumilast • Sulfadoxine | Multiple API targets | |
4‑Chloro-3-sulfamoylbenzoic acid | 1205–30‑7 | • Clopamide • Tripamide | Multiple API targets | |
4‑Chloro-5-sulfamoylsalicylic acid | 14556–98‑0 | Xipamide | ||
4‑Hydroxy-3-pyridinesulfonic acid | 51498–37‑4 | Torsemide | ||
4‑Hydroxybenzophenone | 1137–42‑4 | • Clomiphene • Tamoxifen • Toremifene | Multiple API targets | |
5‑Amino-2-nitrobenzotrifluoride | 393–11‑3 | • Fluridil • Flutamide • Nilutamide | Multiple API targets | |
5‑Bromophthalide | 64169–34‑2 | • Citalopram • Citalopram hydrobromide | Multiple API targets | |
5‑Chloro-o-anisic acid | 3438–16‑2 | Glyburide | ||
5‑Chloro-o-anisic acid methyl ester | 33924–48‑0 | Glyburide | ||
5‑Cyanophthalide | 82104–74‑3 | • Citalopram • Escitalopram | Multiple API targets | |
5′-O-Trityl‑2,3′-anhydrothymidine | 5964–41‑0 | Zidovudine | ||
6‑Amino-2-chloropyridine | 45644–21‑1 | N-(2‑Chloro-4-pyridinyl)-N’-phenylurea | ||
6‑Hydroxy-2-(4‑hydroxyphenyl) benzo (b) thiophene | 63676–22‑2 | Raloxifene | ||
7‑Aminoheptanoic acid hydrochloride | 62643–56‑5 | • Amineptine • Amineptine hydrochloride • Tianeptine Sodium | Multiple API targets | |
7‑Aminoheptanonic Acid ethyl ester hydrochloride | 29840–65‑1 | Tianeptine Sodium | ||
Anisil | 1226–42‑2 | • Flumizole • Idanpramine | Multiple API targets | |
Bis-(2‑chloroethyl)-amine hydrochloride | 821–48‑7 | • 1-(4‑Methoxyphenyl)-piperazine • Cyclophosphamide • Estramustine phosphate • Itraconazole • Ketoconazole • N‑Phenylpiperazine | Multiple API targets | |
Ethyl‑1,4‑benzodioxane-2-carboxylate | 4739–94‑0 | Doxazosin | ||
Glutaric anhydride | 108–55‑4 | Granisetron | ||
Glutaric acid | 110–94‑1 | • 2,6‑Diaminopyridine • Gusperimus trihydrochloride | Multiple API targets | |
Hydrocortisone | 50–23‑7 | Corticosteroids | N/A | |
Methyl 2,3‑dibromopropionate | 1729–67‑5 | Doxazosin | ||
Methyl 2,3‑dihydro‑1,4‑benzodioxine-2-carboxylate | 3663–79‑4 | Doxazosin | ||
Methyl-4-methyl biphenyl-2-carboxylate | 114772–34‑8 | Telmisartan | ||
N-(2‑Chloroethyl)-diethylamine hydrochloride | 869–24‑9 | • 5-(Diethylamino)-2-pentanone • Amiodarone • Butethamate • Butoxycaine hydrochloride • Camylofine • Caroverine • Chloroquine • Chromonar • Diethazine hydrochloride • Diethylaminoethyl cellulose • Doxylamine • Flurazepam • Lucanthone • Nafronyl • Tiropramide | Multiple API targets | |
N-(2‑Chloroethyl)-diisopropylamine hydrochloride | 4261–68‑1 | • Diisopromine • Disopyramide • Isopropamide iodide | Multiple API targets | |
N-(2‑Chloroethyl)-dimethylamine hydrochloride | 4584–46‑7 | • 1-(2‑Dimethylaminoethyl)-5-mercaptotetrazole • Bephenium 3‑hydroxy-2-naphthoate • Brompheniramine • Carbinoxamine • Chloropyramine • Chlorpheniramine • Chlorphenoxamine • Dibenzepin hydrochloride • Dimethindene • Doxylamine • Meclofenoxate • Pheniramine maleate • Phenyltoloxamine • Pyrilamine • Tibezonium iodide • Tripelennamine | Multiple API targets | |
N-(2‑Chloroethyl)-morpholine hydrochloride | 3647–69‑6 | Floredil | ||
N-(2‑Chloroethyl)-piperidine hydrochloride | 2008–75‑5 | Raloxifene | ||
N-(2‑Chloropropyl)-dimethyl amine hydrochloride | 4584–49‑0 | • Isothipendyl hydrochloride • Methadone | Multiple API targets | |
N-(2‑Furoyl)-piperazine | 40172–95‑0 | • Prazosin • Prazosin hydrochloride • Terazosin | Multiple API targets | |
N-(4-(Benzyloxy)benzylidene)-4-fluoroaniline | 70627–52‑0 | Ezetimibe | ||
N-(2′-Cyanobiphenyl-4-ylmethyl)-L-valine methyl ester | 137863–89‑9 | Valsartan | ||
N-(2′-Cyanobiphenyl-4-ylmethyl)-N-pentanoyl-L-valine benzyl ester | N/A | Valsartan | ||
N-[4-[2-(3‑ethyl-4-methyl-2-oxo-3-pyrroline-1-carboximido) ethyl Benzene sulphonamide | 119018–29‑0 | Glimepiride | ||
Sodium butyrate | 156–54‑7 | • Iophenoxic acid • Sodium butyrate | Multiple API targets | |
Thiomorpholine | 123–90‑0 | Sutezolid | ||
Tianeptine Acid | 66981–73‑5 | Tianeptine Sodium |
For information about intermediates product availability and development status please contact us.
FLAVINE EUROPE GMBH
Wehrlestrasse 12
81679 Munich, Germany
Phone: [+49] 89–939-967–0
Fax: [+49] 89–939-967–16
E‑Mail: Flavine-europe@flavine.eu
For information about intermediates product availability and development status please contact us.
FLAVINE NORTH AMERICA INC
61 South Paramus Road, Suite 565
Paramus, NJ 07652, USA
Phone: [+1] 201–768-4190
Fax: [+1] 201–768-2854
E‑Mail: sales@flavine.com
Disclaimers:
Some of the products listed are currently under development and therefore pertinent information may not be available at this time. Any product listed which is covered under current patents is available only for use reasonably related to the development and submission of information to the relevant Health Authorities to the extent permitted under applicable laws regulating the manufacture, use and sale of Active Pharmaceutical Ingredients, and/or their intermediates.